These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 16357)

  • 21. [Acute renal insufficiency due to intentional glafenine poisoning].
    Jerbi Z; Amamou M; Ben Saleh N; Yacoub M
    Tunis Med; 1988; 66(8-9):637-9. PubMed ID: 2905089
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure.
    Davis PJ; Stiller RL; Cook DR; Brandom BW; Davin-Robinson KA
    Anesth Analg; 1988 Mar; 67(3):268-71. PubMed ID: 2964213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of zopiclone pharmacokinetics in patients with impaired renal function and normal subjects. Effect of hemodialysis.
    Marc-Aurele J; Caille G; Bourgoin J
    Sleep; 1987; 10 Suppl 1():22-6. PubMed ID: 3438644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute renal insufficiency caused by glafenine poisoning (proceedings)].
    Estenne M; Naeije R; Ketelbant-Balasse P; Gausset P; Demanet JC
    J Urol Nephrol (Paris); 1979; 85(4-5):342. PubMed ID: 39179
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of aspoxicillin in subjects with normal and impaired renal function.
    Geyer J; Höffler D; Koeppe P
    Arzneimittelforschung; 1988 Nov; 38(11):1635-9. PubMed ID: 3214450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of alfentanil in chronic renal failure.
    Chauvin M; Lebrault C; Levron JC; Duvaldestin P
    Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis.
    Herrero A; Rius Alarcó F; García Díez JM; Mahiques E; Domingo JV
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):84-7. PubMed ID: 3045024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of cicletanine hydrochloride in patients with renal insufficiency].
    Lize JM; Durand JL; Jungers P; Divine C; Bohbot M; Fredj G; Thuillier A
    Therapie; 1987; 42(4):399-402. PubMed ID: 3686476
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of chloroquine in renal insufficiency.
    Salako LA; Walker O; Iyun AO
    Afr J Med Med Sci; 1984; 13(3-4):177-82. PubMed ID: 6099980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in erythromycin pharmacokinetics induced by renal failure.
    Kanfer A; Stamatakis G; Torlotin JC; Fredj G; Kenouch S; Méry JP
    Clin Nephrol; 1987 Mar; 27(3):147-50. PubMed ID: 3494560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Letter: Glaphenine and nephrotoxicity; a side effect?].
    Canta LR
    Ned Tijdschr Geneeskd; 1976 Apr; 120(16):719-20. PubMed ID: 4738
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L; Gorgia A; Marmy A; Tschopp JM
    Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of renal function on the pharmacokinetics of palifermin.
    Gillespie B; Zia-Amirhosseini P; Salfi M; Kakkar T; Wang J; Gupta S; Smith B; Robson R; Sullivan JT
    J Clin Pharmacol; 2006 Dec; 46(12):1460-8. PubMed ID: 17101745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics].
    Nissenson AR; Levin NW; Parker RH
    Arzneimittelforschung; 1974 Sep; 24(9b):1470-3. PubMed ID: 4479806
    [No Abstract]   [Full Text] [Related]  

  • 39. [Letter: Glaphenine-induced shock. 6 recent cases].
    Michaud JL; Doublet L
    Nouv Presse Med; 1976 Mar; 5(11):716. PubMed ID: 4771
    [No Abstract]   [Full Text] [Related]  

  • 40. [An unusual symptom complex as a side effect of glafenine (Glifanan)].
    Burgers GJ; Smeenk G; van der Vegt JH
    Ned Tijdschr Geneeskd; 1976 Mar; 120(12):528-30. PubMed ID: 2883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.